Our analyses showed that RBX1 expression in the immune subtypes of BLCA, UCEC and UVM had no statistical significance, while RBX2 expression in above three cancers was closely related with those immune subtypes. This evidence concerns the gene RNF7 and bladder transitional cell carcinoma.